Comparison of Femoral Versus Jugular Routes for Temporary Hemodialysis in Seriously Ill Patients (CATHEDIA)

November 13, 2014 updated by: University Hospital, Caen

Complications of Jugular and Femoral Venous Catheterization in Critically Ill Patients Requiring Hemodialysis: A Randomized Controlled Trial

The purpose of this study is to determine whether a jugular route leads to a lower rate of complications as compared with a femoral route for catheterization in patients admitted in several intensive care units in France who develop acute renal failure requiring hemodiafiltration or hemodialysis.

Study Overview

Study Type

Interventional

Enrollment (Actual)

750

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Amiens, France, 80000
        • Medical and nephrologic Intensive Care Unit, CHU Amien Sud
      • Argenteuil, France, 95100
        • CH Argenteuil
      • Caen, France, 14033
        • Surgical Intensive Care Unit
      • Caen, France, 14000
        • Medical Intensive Care Unit, CHU de Caen
      • Clermont Ferrand, France
        • Chu de Clermont Ferrand
      • Garches, France, 92380
        • CHU Raymond Pointcarré
      • Paris, France, 75679
        • Hôpital Cochin
      • Paris, France, 75
        • Hôpital Lariboisière
      • Paris, France, 75
        • Hôpital St Joseph
      • Saint Malo, France
        • CH Saint Malo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Admitted in intensive care unit (ICU)
  • Requiring hemodialysis
  • Clinicians have the choice between jugular and femoral routes

Exclusion Criteria:

  • Chronic renal failure requiring long term dialysis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Femoral route
Experimental: Jugular route

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time of insertion without complication

Secondary Outcome Measures

Outcome Measure
Rates of mechanical complications
Rates of infectious complications including cath-colonization
Quality of hemodialysis by urea extraction ratio

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2004

Primary Completion (Actual)

May 1, 2007

Study Completion (Actual)

May 1, 2007

Study Registration Dates

First Submitted

January 13, 2006

First Submitted That Met QC Criteria

January 13, 2006

First Posted (Estimate)

January 18, 2006

Study Record Updates

Last Update Posted (Estimate)

November 14, 2014

Last Update Submitted That Met QC Criteria

November 13, 2014

Last Verified

November 1, 2014

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe